This is a Validated Antibody Database (VAD) review about human HLA-DRB4, based on 69 published articles (read how Labome selects the articles), using HLA-DRB4 antibody in all methods. It is aimed to help Labome visitors find the most suited HLA-DRB4 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
HLA-DRB4 synonym: DR4; DRB4; HLA-DR4B

Invitrogen
mouse monoclonal (TU36)
  • mass cytometry; human; loading ...; fig 2b, 2s8a
Invitrogen HLA-DRB4 antibody (Invitrogen, Tu36) was used in mass cytometry on human samples (fig 2b, 2s8a). elife (2020) ncbi
mouse monoclonal (LN-3)
  • immunohistochemistry; mouse; loading ...; fig 1
Invitrogen HLA-DRB4 antibody (eBioscience, LN3) was used in immunohistochemistry on mouse samples (fig 1). JCI Insight (2019) ncbi
mouse monoclonal (LN3)
  • immunohistochemistry; mouse; loading ...; fig 1
Invitrogen HLA-DRB4 antibody (eBioscience, LN3) was used in immunohistochemistry on mouse samples (fig 1). JCI Insight (2019) ncbi
mouse monoclonal (LN3)
  • flow cytometry; human; loading ...; fig 6c
Invitrogen HLA-DRB4 antibody (Ebioscience, 47-9956-42) was used in flow cytometry on human samples (fig 6c). Oncoimmunology (2019) ncbi
mouse monoclonal (LN3)
  • flow cytometry; human; loading ...; fig 3c
Invitrogen HLA-DRB4 antibody (eBioscience, 12-9956-42) was used in flow cytometry on human samples (fig 3c). Cell Rep (2019) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 3c
Invitrogen HLA-DRB4 antibody (eBioscience, 11-9952-41) was used in flow cytometry on human samples (fig 3c). Cell (2019) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 3a
Invitrogen HLA-DRB4 antibody (eBioscience, L243) was used in flow cytometry on human samples (fig 3a). J Clin Invest (2019) ncbi
mouse monoclonal (LN3)
  • immunohistochemistry; human; 1:1000; loading ...; fig 2f
Invitrogen HLA-DRB4 antibody (eBioscience, 14-99-56-82) was used in immunohistochemistry on human samples at 1:1000 (fig 2f). Clin Exp Immunol (2018) ncbi
mouse monoclonal (LN-3)
  • flow cytometry; human; loading ...; fig st12
In order to identify new types of human blood dendritic cells, monocytes, and progenitors through single-cell RNA-seq, Invitrogen HLA-DRB4 antibody (eBioscience, LN3) was used in flow cytometry on human samples (fig st12). Science (2017) ncbi
mouse monoclonal (LN-3)
  • flow cytometry; human; loading ...; fig 5a
In order to use CRISPR/Cas9 editing to generate reagents to study the role of IRF8 in human hematopoiesis, Invitrogen HLA-DRB4 antibody (eBioscience, LN3) was used in flow cytometry on human samples (fig 5a). Stem Cells (2017) ncbi
mouse monoclonal (LN3)
  • flow cytometry; human; loading ...; fig 5a
In order to use CRISPR/Cas9 editing to generate reagents to study the role of IRF8 in human hematopoiesis, Invitrogen HLA-DRB4 antibody (eBioscience, LN3) was used in flow cytometry on human samples (fig 5a). Stem Cells (2017) ncbi
mouse monoclonal (L243)
  • flow cytometry; rhesus macaque; loading ...; fig 1a
In order to examine frequency and function of myeloid-derived suppressor cells in SIV-infected rhesus macaques, Invitrogen HLA-DRB4 antibody (Fisher Scientific, L243) was used in flow cytometry on rhesus macaque samples (fig 1a). J Immunol (2017) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 1a
In order to study the restoration of immune function in chronic HIV infection, Invitrogen HLA-DRB4 antibody (eBioscience, L240) was used in flow cytometry on human samples (fig 1a). J Clin Invest (2017) ncbi
mouse monoclonal (LN-3)
  • flow cytometry; human; loading ...; fig 4a
In order to compare the effect of CXCL4 and its variant CXCL4L1 on the differentiation of monocytes into macrophages and into immature monocyte-derived dendritic cells, Invitrogen HLA-DRB4 antibody (eBioscience, LN3) was used in flow cytometry on human samples (fig 4a). PLoS ONE (2016) ncbi
mouse monoclonal (TU36)
  • flow cytometry; human; loading ...; fig 1a
In order to measure CD80 and CD86 expression on CD14+HLA-DR+ monocytes from patients with Chagas disease, Invitrogen HLA-DRB4 antibody (Invitrogen, MHLDR31) was used in flow cytometry on human samples (fig 1a). Rev Soc Bras Med Trop (2016) ncbi
mouse monoclonal (T 36)
  • flow cytometry; human; loading ...; fig s2
In order to perform a Cytometry by Time-Of-Flight analysis on primary airway samples obtained from well-characterized patients with asthma and cystic fibrosis, Invitrogen HLA-DRB4 antibody (ThermoFisher Scientific, Q22158) was used in flow cytometry on human samples (fig s2). Cytometry B Clin Cytom (2017) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...
In order to establish the T Cell receptor-inducible costimulator as a promising target for direct T regulatory cell-targeting therapeutic agents for gastric cancer, Invitrogen HLA-DRB4 antibody (eBioscience, L243) was used in flow cytometry on human samples . Int J Cancer (2017) ncbi
mouse monoclonal (LN3)
  • flow cytometry; human; fig 1
Invitrogen HLA-DRB4 antibody (eBioscience, 11-9956) was used in flow cytometry on human samples (fig 1). Stem Cell Reports (2016) ncbi
rat monoclonal (YD1/63.4.10)
  • flow cytometry; human; loading ...; fig 4b
In order to assess dextran-based nanoparticles as a drug delivery system to target myeloid cells of the liver, Invitrogen HLA-DRB4 antibody (Thermo Fisher, MA1-70113) was used in flow cytometry on human samples (fig 4b). Nanomedicine (Lond) (2016) ncbi
mouse monoclonal (T 36)
  • flow cytometry; human; loading ...; fig 1a
In order to investigate how differences in B cell populations may contribute to HIV susceptibility, Invitrogen HLA-DRB4 antibody (Invitrogen, T-36) was used in flow cytometry on human samples (fig 1a). AIDS Res Hum Retroviruses (2016) ncbi
mouse monoclonal (LN3)
  • flow cytometry; human; fig 2
Invitrogen HLA-DRB4 antibody (eBioscience, 45-9956-41) was used in flow cytometry on human samples (fig 2). Stem Cell Reports (2016) ncbi
mouse monoclonal (LN3)
  • flow cytometry; human; loading ...; fig 2f
In order to study the cytolytic effector capacity of HIV-specific CD8+ T cells, Invitrogen HLA-DRB4 antibody (Invitrogen, LN3) was used in flow cytometry on human samples (fig 2f). PLoS Pathog (2016) ncbi
mouse monoclonal (LN-3)
  • flow cytometry; human; loading ...; fig 2f
In order to study the cytolytic effector capacity of HIV-specific CD8+ T cells, Invitrogen HLA-DRB4 antibody (Invitrogen, LN3) was used in flow cytometry on human samples (fig 2f). PLoS Pathog (2016) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; 1:50; fig s2c
In order to develop and characterize a humanized ossicle xenotransplantation approach, Invitrogen HLA-DRB4 antibody (ebioscience, L243) was used in flow cytometry on human samples at 1:50 (fig s2c). Nat Med (2016) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; 1:20; loading ...; fig s5j
In order to describe the role of mTOR signalling in recruiting pro-tumorigenic myeloid-derived suppressor cells., Invitrogen HLA-DRB4 antibody (eBioscience, 12-9952-41) was used in flow cytometry on human samples at 1:20 (fig s5j). Nat Cell Biol (2016) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; fig st1
In order to discuss the impact of filaggrin mutations on the development of atopic dermatitis, Invitrogen HLA-DRB4 antibody (eBiosciences, L243-ef450) was used in flow cytometry on human samples (fig st1). J Allergy Clin Immunol (2016) ncbi
mouse monoclonal (TU36)
  • flow cytometry; human; tbl 2
In order to determine the contribution of Leukocyte Ig Like Receptors to Mycobacterium tuberculosis infection, Invitrogen HLA-DRB4 antibody (Invitrogen, VXMHLDR17) was used in flow cytometry on human samples (tbl 2). Sci Rep (2016) ncbi
mouse monoclonal (LN-3)
  • flow cytometry; African green monkey; loading ...
In order to report that B cells modulate the local granulomatous response in Mycobacterium tuberculosis-infected macaques during acute infection, Invitrogen HLA-DRB4 antibody (eBioscience, LN3) was used in flow cytometry on African green monkey samples . Infect Immun (2016) ncbi
mouse monoclonal (LN3)
  • flow cytometry; African green monkey; loading ...
In order to report that B cells modulate the local granulomatous response in Mycobacterium tuberculosis-infected macaques during acute infection, Invitrogen HLA-DRB4 antibody (eBioscience, LN3) was used in flow cytometry on African green monkey samples . Infect Immun (2016) ncbi
mouse monoclonal (LN3)
  • flow cytometry; human; loading ...; fig 1
In order to characterize the gut-associated lymphoid tissue of HIV-controllers, Invitrogen HLA-DRB4 antibody (eBioscience, LN3) was used in flow cytometry on human samples (fig 1). Immunol Res (2016) ncbi
mouse monoclonal (LN-3)
  • flow cytometry; human; loading ...; fig 1
In order to characterize the gut-associated lymphoid tissue of HIV-controllers, Invitrogen HLA-DRB4 antibody (eBioscience, LN3) was used in flow cytometry on human samples (fig 1). Immunol Res (2016) ncbi
mouse monoclonal (LN3)
  • flow cytometry; human; 1:200; fig st3
Invitrogen HLA-DRB4 antibody (eBioscience, 12-9956-42) was used in flow cytometry on human samples at 1:200 (fig st3). Leukemia (2016) ncbi
mouse monoclonal (TU36)
  • flow cytometry; rhesus macaque; fig 5
In order to characterize functional and phenotypic properties of monoclonal antibodies specific for Rhesus Macaque CD200, Mincle, and CD200R, Invitrogen HLA-DRB4 antibody (Life Technologies, MHLDR17) was used in flow cytometry on rhesus macaque samples (fig 5). PLoS ONE (2015) ncbi
mouse monoclonal (LN3)
  • flow cytometry; human; fig 3
In order to investigate the dynamics and characteristics of natural killer cell types in the human ocular mucosal surface in situ during infection with group D human adenoviruses, Invitrogen HLA-DRB4 antibody (eBioscience, LN3) was used in flow cytometry on human samples (fig 3). Mucosal Immunol (2016) ncbi
mouse monoclonal (LN-3)
  • flow cytometry; human; 5:100; fig s3
In order to show that hepatitis B virus exposure in utero enhances immunity to bacterial infections, Invitrogen HLA-DRB4 antibody (eBioscience, LN3) was used in flow cytometry on human samples at 5:100 (fig s3). Nat Commun (2015) ncbi
mouse monoclonal (LN3)
  • flow cytometry; human; 5:100; fig s3
In order to show that hepatitis B virus exposure in utero enhances immunity to bacterial infections, Invitrogen HLA-DRB4 antibody (eBioscience, LN3) was used in flow cytometry on human samples at 5:100 (fig s3). Nat Commun (2015) ncbi
mouse monoclonal (TU36)
  • flow cytometry; human
In order to study the role of melanoma cell surface-associated calreticulin in melphalan-induced antitumor immunity, Invitrogen HLA-DRB4 antibody (BD, MHLDR01) was used in flow cytometry on human samples . Cancer Res (2015) ncbi
mouse monoclonal (L243)
  • flow cytometry; human
Invitrogen HLA-DRB4 antibody (eBioscience, 25-9952-41) was used in flow cytometry on human samples . Nanomedicine (2015) ncbi
mouse monoclonal (TU36)
  • flow cytometry; human
In order to study the role of autophagy in melanoma, Invitrogen HLA-DRB4 antibody (Life Technologies, MHLDR01) was used in flow cytometry on human samples . Biochem Pharmacol (2015) ncbi
mouse monoclonal (LN3)
  • flow cytometry; human
Invitrogen HLA-DRB4 antibody (eBioscience, 11-9956) was used in flow cytometry on human samples . J Pediatr Surg (2014) ncbi
mouse monoclonal (LN3)
  • flow cytometry; human
Invitrogen HLA-DRB4 antibody (eBioscience, LN3) was used in flow cytometry on human samples . J Allergy Clin Immunol (2015) ncbi
mouse monoclonal (LN3)
  • flow cytometry; human
Invitrogen HLA-DRB4 antibody (eBioscience, LN3) was used in flow cytometry on human samples . Hum Immunol (2015) ncbi
mouse monoclonal (LN3)
  • immunocytochemistry; human
In order to study the role of dendritic cells in relation to T cells, Invitrogen HLA-DRB4 antibody (eBioscience, LN3) was used in immunocytochemistry on human samples . J Immunol (2014) ncbi
mouse monoclonal (LN-3)
  • immunohistochemistry - paraffin section; human; 1:100; fig 2
In order to discuss a meta-analysis of genome-wide association study data on Abeta1-42 and pTau181 in Alzheimer's disease dementia patients, Invitrogen HLA-DRB4 antibody (Thermo, MA1-35420) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 2). Hum Mol Genet (2014) ncbi
mouse monoclonal (LN3)
  • flow cytometry; human
Invitrogen HLA-DRB4 antibody (eBioscience, LN3) was used in flow cytometry on human samples . J Exp Med (2014) ncbi
mouse monoclonal (LN3)
  • flow cytometry; human
Invitrogen HLA-DRB4 antibody (eBioscience, LN3) was used in flow cytometry on human samples . J Immunol (2014) ncbi
mouse monoclonal (LN3)
  • flow cytometry; human
Invitrogen HLA-DRB4 antibody (eBioscience, LN3) was used in flow cytometry on human samples . J Infect Dis (2014) ncbi
mouse monoclonal (LN3)
  • flow cytometry; human
In order to analyze chronic lymphocytic leukemia and how cytokine-driven loss of plasmacytoid dendritic cell function occurs, Invitrogen HLA-DRB4 antibody (eBioscience, LN3) was used in flow cytometry on human samples . Leukemia (2014) ncbi
mouse monoclonal (LN3)
  • flow cytometry; human
Invitrogen HLA-DRB4 antibody (eBioscience, LN3) was used in flow cytometry on human samples . PLoS Pathog (2014) ncbi
mouse monoclonal (TU36)
  • flow cytometry; human; 1:20; fig s6
In order to decipher how susequent acute infection is supressed in T cell responses after exposure to subinfectious hepatitis C virus, Invitrogen HLA-DRB4 antibody (Invitrogen, Tu36) was used in flow cytometry on human samples at 1:20 (fig s6). Nat Med (2013) ncbi
mouse monoclonal (LN3)
  • flow cytometry; human; loading ...; fig 3b
In order to correlate biomarkers associated with coagulation, monocyte activation, and inflammation in elite controllers of HIV infection, Invitrogen HLA-DRB4 antibody (eBioscience, LN3) was used in flow cytometry on human samples (fig 3b). J Infect Dis (2014) ncbi
mouse monoclonal (LN-3)
  • flow cytometry; human; loading ...; fig 3b
In order to correlate biomarkers associated with coagulation, monocyte activation, and inflammation in elite controllers of HIV infection, Invitrogen HLA-DRB4 antibody (eBioscience, LN3) was used in flow cytometry on human samples (fig 3b). J Infect Dis (2014) ncbi
mouse monoclonal (L243)
  • flow cytometry; human
Invitrogen HLA-DRB4 antibody (eBioscience, L243) was used in flow cytometry on human samples . J Hepatol (2014) ncbi
mouse monoclonal (TU36)
  • flow cytometry; human
In order to assess the susceptibility of fetal membranes-derived mesenchymal stromal/stem cells to all members of the human Herpesviridae family, Invitrogen HLA-DRB4 antibody (Caltag Laboratories, clone Tu36) was used in flow cytometry on human samples . PLoS ONE (2013) ncbi
mouse monoclonal (LN-3)
  • immunohistochemistry - paraffin section; rhesus macaque; 1:50; fig 2
In order to optimize rhesus monkey decellularized kidney scaffolds, Invitrogen HLA-DRB4 antibody (Life Technologies, LN3) was used in immunohistochemistry - paraffin section on rhesus macaque samples at 1:50 (fig 2). PLoS ONE (2013) ncbi
mouse monoclonal (LN3)
  • immunohistochemistry - paraffin section; rhesus macaque; 1:50; fig 2
In order to optimize rhesus monkey decellularized kidney scaffolds, Invitrogen HLA-DRB4 antibody (Life Technologies, LN3) was used in immunohistochemistry - paraffin section on rhesus macaque samples at 1:50 (fig 2). PLoS ONE (2013) ncbi
mouse monoclonal (TU36)
  • flow cytometry; rhesus macaque; loading ...; fig 2a
In order to test if vaccination alters the activation state of T cells within the gastrointestinal mucosa, inguinal lymph nodes, and peripheral blood, Invitrogen HLA-DRB4 antibody (Invitrogen, TU36) was used in flow cytometry on rhesus macaque samples (fig 2a). Hum Vaccin Immunother (2012) ncbi
mouse monoclonal (TU36)
  • flow cytometry; human
In order to study the diverse functions of li in DCs, Invitrogen HLA-DRB4 antibody (Caltag Laboratories, MHLDR05) was used in flow cytometry on human samples . J Leukoc Biol (2012) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; fig S2
In order to examine tumor and nonadjacent normal breast tissue from women with breast cancer, who either had or had not received neoadjuvant chemotherapy before surgery, Invitrogen HLA-DRB4 antibody (eBioscience, 48-9952-42) was used in flow cytometry on human samples (fig S2). Proc Natl Acad Sci U S A (2012) ncbi
mouse monoclonal (LN3)
  • immunohistochemistry - paraffin section; rhesus macaque; 1:200; tbl 2
  • flow cytometry; rhesus macaque; fig 7
In order to study the host inflammatory granulomatous response that controls cutaneous leishmaniasis using a macaque model, Invitrogen HLA-DRB4 antibody (Zymed Laboratory, clone LN-3) was used in immunohistochemistry - paraffin section on rhesus macaque samples at 1:200 (tbl 2) and in flow cytometry on rhesus macaque samples (fig 7). J Pathol (2008) ncbi
mouse monoclonal (LN-3)
  • immunohistochemistry - paraffin section; rhesus macaque; 1:200; tbl 2
  • flow cytometry; rhesus macaque; fig 7
In order to study the host inflammatory granulomatous response that controls cutaneous leishmaniasis using a macaque model, Invitrogen HLA-DRB4 antibody (Zymed Laboratory, clone LN-3) was used in immunohistochemistry - paraffin section on rhesus macaque samples at 1:200 (tbl 2) and in flow cytometry on rhesus macaque samples (fig 7). J Pathol (2008) ncbi
mouse monoclonal (TU36)
  • flow cytometry; human; 1:50
In order to describe a culture method for directed differentiation of human embryonic stem cells to dendritic cells, Invitrogen HLA-DRB4 antibody (Caltag, MHLDR04) was used in flow cytometry on human samples at 1:50. Methods Mol Biol (2007) ncbi
mouse monoclonal (TU36)
  • immunohistochemistry; human; fig 2
In order to characterize the frequency of potential targets of HIV infection within the female reproductive tract, Invitrogen HLA-DRB4 antibody (Caltag, MHLDR01) was used in immunohistochemistry on human samples (fig 2). Immunology (2004) ncbi
mouse monoclonal (TU36)
  • flow cytometry; human
In order to study CD45 splice variants in patients with hemophagocytic lymphohistiocytosis, Invitrogen HLA-DRB4 antibody (Caltag, TU36) was used in flow cytometry on human samples . Pediatr Res (2004) ncbi
mouse monoclonal (TU36)
  • flow cytometry; human
In order to test if CD103 has a regulatory role in the microenvironment of the epithelial cell layer, Invitrogen HLA-DRB4 antibody (Caltag, TU36) was used in flow cytometry on human samples . Cytometry B Clin Cytom (2003) ncbi
mouse monoclonal (TU36)
  • flow cytometry; human; fig 4
In order to report that CD34(+) progenitor cell-derived Langerhans cells-type DCs exhibit a differentiation state-dependent susceptibility to CMV infection, Invitrogen HLA-DRB4 antibody (Caltag, TU36) was used in flow cytometry on human samples (fig 4). J Virol (2003) ncbi
mouse monoclonal (LN3)
  • immunohistochemistry - frozen section; human; fig 6
  • flow cytometry; human; fig 4
In order to determine the expression of a human macrophage lectin specific for galactose/N-acetylgalactosamine during macrophage differentiation, Invitrogen HLA-DRB4 antibody (Zymed, LN-3) was used in immunohistochemistry - frozen section on human samples (fig 6) and in flow cytometry on human samples (fig 4). Int Immunol (2002) ncbi
mouse monoclonal (LN-3)
  • immunohistochemistry - frozen section; human; fig 6
  • flow cytometry; human; fig 4
In order to determine the expression of a human macrophage lectin specific for galactose/N-acetylgalactosamine during macrophage differentiation, Invitrogen HLA-DRB4 antibody (Zymed, LN-3) was used in immunohistochemistry - frozen section on human samples (fig 6) and in flow cytometry on human samples (fig 4). Int Immunol (2002) ncbi
mouse monoclonal (TU36)
  • flow cytometry; human
In order to study perturbations in eosinophil homeostasis following treatment of lymphatic filariasis, Invitrogen HLA-DRB4 antibody (Caltag, TU 36) was used in flow cytometry on human samples . Infect Immun (2000) ncbi
mouse monoclonal (TU36)
  • flow cytometry; human
In order to report that the expression of CD41 and c-mpl were not predictive of commitment to the megakaryocyte lineage, Invitrogen HLA-DRB4 antibody (Caltag, TU36) was used in flow cytometry on human samples . Br J Haematol (1999) ncbi
mouse monoclonal (TU36)
  • flow cytometry; human
In order to determine the number of CD4, CCR5, and CXCR4 antibody-binding sites on various T cells and macrophages, Invitrogen HLA-DRB4 antibody (Caltag, TU36) was used in flow cytometry on human samples . Proc Natl Acad Sci U S A (1999) ncbi
Miltenyi Biotec
human monoclonal (REA332)
  • flow cytometry; human; 1:200; loading ...; fig 2s1a
Miltenyi Biotec HLA-DRB4 antibody (Miltenyi Biotec, REA332) was used in flow cytometry on human samples at 1:200 (fig 2s1a). elife (2020) ncbi
mouse monoclonal (AC122)
  • flow cytometry; human; loading ...; fig 4c
Miltenyi Biotec HLA-DRB4 antibody (Miltenyi Biotec, AC122) was used in flow cytometry on human samples (fig 4c). Cell Death Dis (2019) ncbi
human monoclonal (REA332)
  • flow cytometry; human; loading ...; fig s3j
Miltenyi Biotec HLA-DRB4 antibody (Miltenyi Biotec, REA332) was used in flow cytometry on human samples (fig s3j). Biol Blood Marrow Transplant (2018) ncbi
human monoclonal (REA332)
  • flow cytometry; human; loading ...; fig st1
Miltenyi Biotec HLA-DRB4 antibody (Miltenyi, REA332) was used in flow cytometry on human samples (fig st1). Front Immunol (2017) ncbi
human monoclonal (REA332)
  • flow cytometry; human; 1:20; loading ...; fig 6a
Miltenyi Biotec HLA-DRB4 antibody (Miltenyi Biotec, REA332) was used in flow cytometry on human samples at 1:20 (fig 6a). J Immunol (2017) ncbi
human monoclonal (REA332)
  • flow cytometry; human; loading ...; fig 1a
In order to develop a recombinant Saccharomyces cerevisiae as a vehicle to deliver genes to primary human macrophages, Miltenyi Biotec HLA-DRB4 antibody (Miltenyi Biotec, REA332) was used in flow cytometry on human samples (fig 1a). Eur J Pharm Biopharm (2017) ncbi
human monoclonal (REA332)
  • flow cytometry; human; fig 1
In order to analyze how Saccharomyces cerevisiae interacts with different macrophage subsets, Miltenyi Biotec HLA-DRB4 antibody (Miltenyi Biotec, REA332) was used in flow cytometry on human samples (fig 1). Inflammation (2016) ncbi
Santa Cruz Biotechnology
mouse monoclonal (ML11C11)
  • immunohistochemistry - paraffin section; human; 1:50; fig 1
Santa Cruz Biotechnology HLA-DRB4 antibody (santa Cruz, sc-73366) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 1). PLoS ONE (2016) ncbi
Articles Reviewed
  1. Ma T, Luo X, George A, Mukherjee G, Sen N, Spitzer T, et al. HIV efficiently infects T cells from the endometrium and remodels them to promote systemic viral spread. elife. 2020;9: pubmed publisher
  2. Shnayder M, Nachshon A, Rozman B, Bernshtein B, Lavi M, Fein N, et al. Single cell analysis reveals human cytomegalovirus drives latently infected cells towards an anergic-like monocyte state. elife. 2020;9: pubmed publisher
  3. Raphael I, Gomez Rivera F, Raphael R, Robinson R, Nalawade S, Forsthuber T. TNFR2 limits proinflammatory astrocyte functions during EAE induced by pathogenic DR2b-restricted T cells. JCI Insight. 2019;4: pubmed publisher
  4. Findlay E, Currie A, Zhang A, Ovciarikova J, Young L, Stevens H, et al. Exposure to the antimicrobial peptide LL-37 produces dendritic cells optimized for immunotherapy. Oncoimmunology. 2019;8:1608106 pubmed publisher
  5. Dumont A, de Rosny C, Kieu T, Perrey S, Berger H, Fluckiger A, et al. Docosahexaenoic acid inhibits both NLRP3 inflammasome assembly and JNK-mediated mature IL-1β secretion in 5-fluorouracil-treated MDSC: implication in cancer treatment. Cell Death Dis. 2019;10:485 pubmed publisher
  6. Celis Gutierrez J, Blattmann P, Zhai Y, Jarmuzynski N, Ruminski K, Gregoire C, et al. Quantitative Interactomics in Primary T Cells Provides a Rationale for Concomitant PD-1 and BTLA Coinhibitor Blockade in Cancer Immunotherapy. Cell Rep. 2019;27:3315-3330.e7 pubmed publisher
  7. Georgouli M, Herraiz C, Crosas Molist E, Fanshawe B, Maiques O, Perdrix A, et al. Regional Activation of Myosin II in Cancer Cells Drives Tumor Progression via a Secretory Cross-Talk with the Immune Microenvironment. Cell. 2019;176:757-774.e23 pubmed publisher
  8. Perciani C, Farah B, Kaul R, Ostrowski M, Mahmud S, Anzala O, et al. Live attenuated varicella-zoster virus vaccine does not induce HIV target cell activation. J Clin Invest. 2019;129:875-886 pubmed publisher
  9. Gorter R, Nutma E, Jahrei M, de Jonge J, Quinlan R, van der Valk P, et al. Heat shock proteins are differentially expressed in brain and spinal cord: implications for multiple sclerosis. Clin Exp Immunol. 2018;194:137-152 pubmed publisher
  10. Fan X, Guo D, Cheung A, Poon Z, Yap C, Goh S, et al. Mesenchymal Stromal Cell (MSC)-Derived Combination of CXCL5 and Anti-CCL24 Is Synergistic and Superior to MSC and Cyclosporine for the Treatment of Graft-versus-Host Disease. Biol Blood Marrow Transplant. 2018;24:1971-1980 pubmed publisher
  11. Delso Vallejo M, Kollet J, Koehl U, Huppert V. Influence of Irradiated Peripheral Blood Mononuclear Cells on Both Ex Vivo Proliferation of Human Natural Killer Cells and Change in Cellular Property. Front Immunol. 2017;8:854 pubmed publisher
  12. Villani A, Satija R, Reynolds G, Sarkizova S, Shekhar K, Fletcher J, et al. Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors. Science. 2017;356: pubmed publisher
  13. Borriello F, Iannone R, Di Somma S, Vastolo V, Petrosino G, Visconte F, et al. Lipopolysaccharide-Elicited TSLPR Expression Enriches a Functionally Discrete Subset of Human CD14+ CD1c+ Monocytes. J Immunol. 2017;198:3426-3435 pubmed publisher
  14. Seif M, Hoppstädter J, Breinig F, Kiemer A. Yeast-mediated mRNA delivery polarizes immuno-suppressive macrophages towards an immuno-stimulatory phenotype. Eur J Pharm Biopharm. 2017;117:1-13 pubmed publisher
  15. Sontag S, Förster M, Qin J, Wanek P, Mitzka S, Schüler H, et al. Modelling IRF8 Deficient Human Hematopoiesis and Dendritic Cell Development with Engineered iPS Cells. Stem Cells. 2017;35:898-908 pubmed publisher
  16. Dross S, Munson P, Kim S, Bratt D, Tunggal H, Gervassi A, et al. Kinetics of Myeloid-Derived Suppressor Cell Frequency and Function during Simian Immunodeficiency Virus Infection, Combination Antiretroviral Therapy, and Treatment Interruption. J Immunol. 2017;198:757-766 pubmed publisher
  17. Zhen A, Rezek V, Youn C, Lam B, Chang N, Rick J, et al. Targeting type I interferon-mediated activation restores immune function in chronic HIV infection. J Clin Invest. 2017;127:260-268 pubmed publisher
  18. Gouwy M, Ruytinx P, Radice E, Claudi F, Van Raemdonck K, Bonecchi R, et al. CXCL4 and CXCL4L1 Differentially Affect Monocyte Survival and Dendritic Cell Differentiation and Phagocytosis. PLoS ONE. 2016;11:e0166006 pubmed publisher
  19. Soares A, Neves P, Cavalcanti M, Marinho S, Oliveira W, Souza J, et al. Expression of co-stimulatory molecules CD80 and CD86 is altered in CD14 + HLA-DR + monocytes from patients with Chagas disease following induction by Trypanosoma cruzi recombinant antigens. Rev Soc Bras Med Trop. 2016;49:632-636 pubmed publisher
  20. Yao Y, Welp T, Liu Q, Niu N, Wang X, Britto C, et al. Multiparameter Single Cell Profiling of Airway Inflammatory Cells. Cytometry B Clin Cytom. 2017;92:12-20 pubmed publisher
  21. Nagase H, Takeoka T, Urakawa S, Morimoto Okazawa A, Kawashima A, Iwahori K, et al. ICOS+ Foxp3+ TILs in gastric cancer are prognostic markers and effector regulatory T cells associated with Helicobacter pylori. Int J Cancer. 2017;140:686-695 pubmed publisher
  22. Sugita S, Iwasaki Y, Makabe K, Kimura T, Futagami T, Suegami S, et al. Lack of T Cell Response to iPSC-Derived Retinal Pigment Epithelial Cells from HLA Homozygous Donors. Stem Cell Reports. 2016;7:619-634 pubmed publisher
  23. Foerster F, Bamberger D, Schupp J, Weilbächer M, Kaps L, Strobl S, et al. Dextran-based therapeutic nanoparticles for hepatic drug delivery. Nanomedicine (Lond). 2016;11:2663-2677 pubmed
  24. Keefer M, Zheng B, Rosenberg A, Kobie J. Increased Steady-State Memory B Cell Subsets Among High-Risk Participants in an HIV Vaccine Trial. AIDS Res Hum Retroviruses. 2016;32:1143-1148 pubmed
  25. Yao Y, Deng Q, Song W, Zhang H, Li Y, Yang Y, et al. MIF Plays a Key Role in Regulating Tissue-Specific Chondro-Osteogenic Differentiation Fate of Human Cartilage Endplate Stem Cells under Hypoxia. Stem Cell Reports. 2016;7:249-62 pubmed publisher
  26. Demers K, Makedonas G, Buggert M, Eller M, Ratcliffe S, Goonetilleke N, et al. Temporal Dynamics of CD8+ T Cell Effector Responses during Primary HIV Infection. PLoS Pathog. 2016;12:e1005805 pubmed publisher
  27. Seif M, Philippi A, Breinig F, Kiemer A, Hoppstädter J. Yeast (Saccharomyces cerevisiae) Polarizes Both M-CSF- and GM-CSF-Differentiated Macrophages Toward an M1-Like Phenotype. Inflammation. 2016;39:1690-703 pubmed publisher
  28. Reinisch A, Thomas D, Corces M, Zhang X, Gratzinger D, Hong W, et al. A humanized bone marrow ossicle xenotransplantation model enables improved engraftment of healthy and leukemic human hematopoietic cells. Nat Med. 2016;22:812-21 pubmed publisher
  29. Welte T, Kim I, Tian L, Gao X, Wang H, Li J, et al. Oncogenic mTOR signalling recruits myeloid-derived suppressor cells to promote tumour initiation. Nat Cell Biol. 2016;18:632-44 pubmed publisher
  30. Rai V, Rao V, Shao Z, Agrawal D. Dendritic Cells Expressing Triggering Receptor Expressed on Myeloid Cells-1 Correlate with Plaque Stability in Symptomatic and Asymptomatic Patients with Carotid Stenosis. PLoS ONE. 2016;11:e0154802 pubmed publisher
  31. Leitch C, Natafji E, Yu C, Abdul Ghaffar S, Madarasingha N, Venables Z, et al. Filaggrin-null mutations are associated with increased maturation markers on Langerhans cells. J Allergy Clin Immunol. 2016;138:482-490.e7 pubmed publisher
  32. Hogan L, Jones D, Allen R. Expression of the innate immune receptor LILRB5 on monocytes is associated with mycobacteria exposure. Sci Rep. 2016;6:21780 pubmed publisher
  33. Phuah J, Wong E, Gideon H, Maiello P, Coleman M, Hendricks M, et al. Effects of B Cell Depletion on Early Mycobacterium tuberculosis Infection in Cynomolgus Macaques. Infect Immun. 2016;84:1301-1311 pubmed publisher
  34. Gonzalez S, Taborda N, Correa L, Castro G, Hernandez J, Montoya C, et al. Particular activation phenotype of T cells expressing HLA-DR but not CD38 in GALT from HIV-controllers is associated with immune regulation and delayed progression to AIDS. Immunol Res. 2016;64:765-74 pubmed publisher
  35. Brown P, Wong K, Felce S, Lyne L, Spearman H, Soilleux E, et al. FOXP1 suppresses immune response signatures and MHC class II expression in activated B-cell-like diffuse large B-cell lymphomas. Leukemia. 2016;30:605-16 pubmed publisher
  36. Byrareddy S, Little D, Mayne A, Villinger F, Ansari A. Phenotypic and Functional Characterization of Monoclonal Antibodies with Specificity for Rhesus Macaque CD200, CD200R and Mincle. PLoS ONE. 2015;10:e0140689 pubmed publisher
  37. Yawata N, Selva K, Liu Y, Tan K, Lee A, Siak J, et al. Dynamic change in natural killer cell type in the human ocular mucosa in situ as means of immune evasion by adenovirus infection. Mucosal Immunol. 2016;9:159-70 pubmed publisher
  38. Hong M, Sandalova E, Low D, Gehring A, Fieni S, Amadei B, et al. Trained immunity in newborn infants of HBV-infected mothers. Nat Commun. 2015;6:6588 pubmed publisher
  39. Dudek Perić A, Ferreira G, Muchowicz A, Wouters J, Prada N, Martin S, et al. Antitumor immunity triggered by melphalan is potentiated by melanoma cell surface-associated calreticulin. Cancer Res. 2015;75:1603-14 pubmed publisher
  40. Fytianos K, Rodríguez Lorenzo L, Clift M, Blank F, Vanhecke D, von Garnier C, et al. Uptake efficiency of surface modified gold nanoparticles does not correlate with functional changes and cytokine secretion in human dendritic cells in vitro. Nanomedicine. 2015;11:633-44 pubmed publisher
  41. Martin S, Dudek Perić A, Maes H, Garg A, Gabrysiak M, Demirsoy S, et al. Concurrent MEK and autophagy inhibition is required to restore cell death associated danger-signalling in Vemurafenib-resistant melanoma cells. Biochem Pharmacol. 2015;93:290-304 pubmed publisher
  42. Vadasz S, JENSEN T, Moncada C, Girard E, Zhang F, Blanchette A, et al. Second and third trimester amniotic fluid mesenchymal stem cells can repopulate a de-cellularized lung scaffold and express lung markers. J Pediatr Surg. 2014;49:1554-63 pubmed publisher
  43. Van Eyck L, Hershfield M, Pombal D, Kelly S, Ganson N, Moens L, et al. Hematopoietic stem cell transplantation rescues the immunologic phenotype and prevents vasculopathy in patients with adenosine deaminase 2 deficiency. J Allergy Clin Immunol. 2015;135:283-7.e5 pubmed publisher
  44. Rueda C, Wells C, Gisslen T, Jobe A, Kallapur S, Chougnet C. Effect of chorioamnionitis on regulatory T cells in moderate/late preterm neonates. Hum Immunol. 2015;76:65-73 pubmed publisher
  45. Yu C, Becker C, Metang P, Marches F, Wang Y, Toshiyuki H, et al. Human CD141+ dendritic cells induce CD4+ T cells to produce type 2 cytokines. J Immunol. 2014;193:4335-43 pubmed publisher
  46. Ramirez A, van der Flier W, Herold C, Ramonet D, Heilmann S, Lewczuk P, et al. SUCLG2 identified as both a determinator of CSF A?1-42 levels and an attenuator of cognitive decline in Alzheimer's disease. Hum Mol Genet. 2014;23:6644-58 pubmed publisher
  47. Longman R, Diehl G, Victorio D, Huh J, Galan C, Miraldi E, et al. CX?CR1? mononuclear phagocytes support colitis-associated innate lymphoid cell production of IL-22. J Exp Med. 2014;211:1571-83 pubmed publisher
  48. Balan S, Ollion V, Colletti N, Chelbi R, Montanana Sanchis F, Liu H, et al. Human XCR1+ dendritic cells derived in vitro from CD34+ progenitors closely resemble blood dendritic cells, including their adjuvant responsiveness, contrary to monocyte-derived dendritic cells. J Immunol. 2014;193:1622-35 pubmed publisher
  49. Wilson E, Singh A, Hullsiek K, Gibson D, Henry W, Lichtenstein K, et al. Monocyte-activation phenotypes are associated with biomarkers of inflammation and coagulation in chronic HIV infection. J Infect Dis. 2014;210:1396-406 pubmed publisher
  50. Saulep Easton D, Vincent F, Le Page M, Wei A, Ting S, Croce C, et al. Cytokine-driven loss of plasmacytoid dendritic cell function in chronic lymphocytic leukemia. Leukemia. 2014;28:2005-15 pubmed publisher
  51. Sereti I, Estes J, Thompson W, Morcock D, Fischl M, Croughs T, et al. Decreases in colonic and systemic inflammation in chronic HIV infection after IL-7 administration. PLoS Pathog. 2014;10:e1003890 pubmed publisher
  52. Park S, Veerapu N, Shin E, Biancotto A, McCoy J, Capone S, et al. Subinfectious hepatitis C virus exposures suppress T cell responses against subsequent acute infection. Nat Med. 2013;19:1638-42 pubmed publisher
  53. Krishnan S, Wilson E, Sheikh V, Rupert A, Mendoza D, Yang J, et al. Evidence for innate immune system activation in HIV type 1-infected elite controllers. J Infect Dis. 2014;209:931-9 pubmed publisher
  54. Tan A, Hoang L, Chin D, Rasmussen E, Lopatin U, Hart S, et al. Reduction of HBV replication prolongs the early immunological response to IFN? therapy. J Hepatol. 2014;60:54-61 pubmed publisher
  55. Avanzi S, Leoni V, Rotola A, Alviano F, Solimando L, Lanzoni G, et al. Susceptibility of human placenta derived mesenchymal stromal/stem cells to human herpesviruses infection. PLoS ONE. 2013;8:e71412 pubmed publisher
  56. Nakayama K, Lee C, Batchelder C, Tarantal A. Tissue specificity of decellularized rhesus monkey kidney and lung scaffolds. PLoS ONE. 2013;8:e64134 pubmed publisher
  57. Reuter M, Yuan S, Marx P, Kutzler M, Weiner D, Betts M. DNA-based HIV vaccines do not induce generalized activation in mucosal tissue T cells. Hum Vaccin Immunother. 2012;8:1648-53 pubmed publisher
  58. Landsverk O, Ottesen A, Berg Larsen A, Appel S, Bakke O. Differential regulation of MHC II and invariant chain expression during maturation of monocyte-derived dendritic cells. J Leukoc Biol. 2012;91:729-37 pubmed publisher
  59. Ruffell B, Au A, Rugo H, Esserman L, Hwang E, Coussens L. Leukocyte composition of human breast cancer. Proc Natl Acad Sci U S A. 2012;109:2796-801 pubmed publisher
  60. Souza Lemos C, de Campos S, Teva A, Corte Real S, Fonseca E, Porrozzi R, et al. Dynamics of immune granuloma formation in a Leishmania braziliensis-induced self-limiting cutaneous infection in the primate Macaca mulatta. J Pathol. 2008;216:375-86 pubmed publisher
  61. Vodyanik M, Slukvin I. Directed differentiation of human embryonic stem cells to dendritic cells. Methods Mol Biol. 2007;407:275-93 pubmed publisher
  62. Yeaman G, Asin S, Weldon S, Demian D, Collins J, Gonzalez J, et al. Chemokine receptor expression in the human ectocervix: implications for infection by the human immunodeficiency virus-type I. Immunology. 2004;113:524-33 pubmed
  63. Boxall S, McCormick J, Beverley P, Strobel S, De Filippi P, Dawes R, et al. Abnormal cell surface antigen expression in individuals with variant CD45 splicing and histiocytosis. Pediatr Res. 2004;55:478-84 pubmed
  64. Braun R, Foerster M, Grahmann P, Haefner D, Workalemahu G, Kroegel C. Phenotypic and molecular characterization of CD103+ CD4+ T cells in bronchoalveolar lavage from patients with interstitial lung diseases. Cytometry B Clin Cytom. 2003;54:19-27 pubmed
  65. Hertel L, Lacaille V, Strobl H, Mellins E, Mocarski E. Susceptibility of immature and mature Langerhans cell-type dendritic cells to infection and immunomodulation by human cytomegalovirus. J Virol. 2003;77:7563-74 pubmed
  66. Higashi N, Morikawa A, Fujioka K, Fujita Y, Sano Y, Miyata Takeuchi M, et al. Human macrophage lectin specific for galactose/N-acetylgalactosamine is a marker for cells at an intermediate stage in their differentiation from monocytes into macrophages. Int Immunol. 2002;14:545-54 pubmed
  67. Gopinath R, Hanna L, Kumaraswami V, Perumal V, Kavitha V, Vijayasekaran V, et al. Perturbations in eosinophil homeostasis following treatment of lymphatic filariasis. Infect Immun. 2000;68:93-9 pubmed
  68. Basch R, Zhang X, Dolzhanskiy A, Karpatkin S. Expression of CD41 and c-mpl does not indicate commitment to the megakaryocyte lineage during haemopoietic development. Br J Haematol. 1999;105:1044-54 pubmed
  69. Lee B, Sharron M, Montaner L, Weissman D, Doms R. Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages. Proc Natl Acad Sci U S A. 1999;96:5215-20 pubmed